Kubin ruling extends KSR logic to biotech
The US Court of Appeals for the Federal Circuit last week ruled in a closely watched biotechnology case that an invention relating to the isolation and sequencing of a human gene was “obvious to try”
The case, In re Kubin, stems from an appeal of a 2007 USPTO Board of Patent Appeals and Interferences (BPAI) decision that applied the landmark Supreme Court ruling in KSR v Teleflex, which rejected the Federal Circuit's rigid teaching-suggestion-motivation (TSM)...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.